Prognostic Significance of the Risk of Non-localized Disease on PSMA/PET: Comparative Performance of a Novel, PSMA/PET-Derived Risk Stratification Tool for High-Risk Prostate Cancer in a Large, Multi-Institutional Cohort

T M Ma,M Xiang, D Tilki,R J Karnes,B J Stish, R Martinez-Monge,R D Tendulkar,E A Klein,P T Tran,J Tosoian,A Berlin,J D Tward,G S Merrick,D E Spratt,D J Krauss,E M Horwitz,A Gafita,T Grogan,J Calais,A U Kishan

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS（2021）

Cited 2|Views14

No score

Abstract

A nomogram tuned to the detection of non-localized disease on PSMA/PET in HR-PCa patients is significantly prognostic of important clinical endpoints, with performance comparable to STAR-CAP and superior to other tools. These data strongly suggest that upstaging based on PSMA PET/CT provides clinically relevant information and warrant prospective validation.

Translated text

Key words

prostate cancer,risk stratification tool,prognostic significance,non-localized,pet-derived,high-risk,multi-institutional

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined